The Ministry of Health, through the Pharmacy and Poisons Board, has recommended the registration of Lenacapavir, a long-acting antiretroviral medicine for HIV pre-exposure prophylaxis (PrEP). In a statement dated Saturday, 10, 2026, Health CS Aden Duale stated that the approval covers Lenacapavir 300 mg tablets and Lenacapavir 464 mg injectable solution. “The Ministry of Health,
President William Ruto has responded to former Deputy President (DP) Rigathi Gachagua over the debate on whether national schools should be reserved for local communities within their respective regions. Speaking at the Nyota Business Start-Up Capital Disbursement event in Eldoret, Uasin Gishu County, on Thursday, January 8, 2026, the President accused Gachagua of promoting tribal
Popular Posts
